GRTS
Gritstone Oncology Inc
Price:  
0.03 
USD
Volume:  
61,017,984.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GRTS Intrinsic Value

-126,298.20 %
Upside

What is the intrinsic value of GRTS?

As of 2025-06-17, the Intrinsic Value of Gritstone Oncology Inc (GRTS) is (40.64) USD. This GRTS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 0.03 USD, the upside of Gritstone Oncology Inc is -126,298.20%.

The range of the Intrinsic Value is (75.19) - (28.44) USD

Is GRTS undervalued or overvalued?

Based on its market price of 0.03 USD and our intrinsic valuation, Gritstone Oncology Inc (GRTS) is overvalued by 126,298.20%.

Note: result may not be accurate due to the invalid valuation result of DCF model.

0.03 USD
Stock Price
(40.64) USD
Intrinsic Value
Intrinsic Value Details

GRTS Intrinsic Value - Valuation Summary

Range Selected Upside
a
DCF (Growth 5y) (75.19) - (28.44) (40.64) -126298.2%
DCF (Growth 10y) (28.62) - (68.98) (39.18) -121771.8%
DCF (EBITDA 5y) (18.79) - (19.52) (1,234.50) -123450.0%
DCF (EBITDA 10y) (20.75) - (21.97) (1,234.50) -123450.0%
Fair Value -13.14 - -13.14 -13.14 -40,906.52%
P/E (64.75) - (104.59) (77.79) -241674.2%
EV/EBITDA (50.19) - (30.28) (54.18) -168375.2%
EPV (22.44) - (24.91) (23.68) -73636.8%
DDM - Stable (3.33) - (7.02) (5.18) -16183.6%
DDM - Multi (0.90) - (1.67) (1.18) -3776.0%

GRTS Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 1.63
Beta 2.51
Outstanding shares (mil) 50.62
Enterprise Value (mil) -8.76
Market risk premium 4.60%
Cost of Equity 48.42%
Cost of Debt 7.00%
WACC 6.83%